Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

205.88 +0.13 (+0.07%)
Streaming Delayed Price Updated: 10:22 AM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments
From Johnson & Johnson
Via Business Wire
News headline image
Johnson’s Junk Removal Launches Full-Service Junk Removal in Kenmore
Via Get News
News headline image
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
Biotech Valuations Rise as New Clinical Platforms Show Progress
From BioMedWire
Via GlobeNewswire
News headline image
Johnson & Johnson Set to Revolutionize the Treatment of Cancer With the Acquisition of Halda Therapeutics
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Participate in the Citi’s 2025 Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
Johnson Y-Axis Adjustment(R) (\"Ring Dinger(R)\") Clarified as In-Scope Care Under Texas Law; Advanced Chiropractic Equipment LLC Addresses Confusion with Y-Strap Traction
Houston, Texas--(Newsfile Corp. - October 20, 2025) - Advanced Chiropractic Equipment LLC (ACE) and Your Houston Chiropractor, Gregory E. Johnson,... 
Via Newsfile
News headline image
Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOVA),(NYSE:MRK),(NYSE:LLY),(NYSE:JNJ) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2025
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Reports Q3 2025 Results; Raises 2025 Sales Outlook
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson recommends shareholders reject “mini-tender” offer by Tutanota
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Participate in the UBS Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Elects John Morikis, Retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company, to its Board of Directors
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Participate in the Bernstein 2nd Annual Healthcare Forum
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook
From Johnson & Johnson
Via Business Wire
News headline image
Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity
EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(NASDAQ:TEM) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
From Johnson & Johnson
Via Business Wire
News headline image
FDA Panel Reiterates the Cancer Risks of Talc
From Beasley Allen Law Firm
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.